CG
NERV icon

Cutler Group’s Minerva Neurosciences NERV Stock Holding History

Cutler Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$2K – 5277
2020
Q3 		$2K Sell
100
-50
-33% -$1.35K ﹤0.01% 4081
2020
Q2 		$4K Buy
150
+87
+138% +$5.1K ﹤0.01% 3477
2020
Q1 		$3K Sell
63
-225
-78% -$13.6K ﹤0.01% 3332
2019
Q4 		$16K Buy
+288
New +$12.7K ﹤0.01% 2348

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's NERV Position: Q4 2020 in Review

Cutler Group sold out of Minerva Neurosciences (NERV) in Q4 2020, closing a stake of 100 shares — an estimated $2K sold.

Cutler Group first reported a position in NERV in Q4 2019 and held it in 4 quarters. The position peaked at $16K in Q4 2019. 76 funds tracked by Wall St. Rank hold NERV as of Q4 2020.

  • Cutler Group reported no remaining Minerva Neurosciences position as of Q4 2020 after selling out during the quarter.
  • Cutler Group sold 100 Minerva Neurosciences shares in Q4 2020, an estimated $2K.
  • Cutler Group first reported a position in Minerva Neurosciences in Q4 2019 and held it in 4 quarters.
  • Cutler Group's Minerva Neurosciences position peaked at $16K in Q4 2019.
  • 76 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.